Surrozen, Inc./DE
For the period ended Dec 31, 2025. Filed Mar 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 23, 2026
SRZN$32.64+2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except per share amounts)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Collaboration and license revenue | $— | $10,000 |
| Research service revenue - related party | 3,477 | 655 |
| Total revenue | 3,477 | 10,655 |
| Operating expenses: | ||
| Research and development | 29,365 | 21,132 |
| General and administrative | 16,204 | 15,062 |
| Total operating expenses | 45,569 | 36,194 |
| Loss from operations | (42,092) | (25,539) |
| Interest income | 3,020 | 1,693 |
| Loss on issuance of common stock, pre-funded warrants and warrants in the 2024 PIPE | — | (20,397) |
| Loss on amendment and cancellation of warrants | (2,073) | — |
| Loss on execution of the 2025 PIPE | (71,084) | — |
| Loss on change in fair value of tranche liability | (104,847) | — |
| Gain on settlement of tranche liability | 1,362 | — |
| Other expense, net | (26,312) | (19,321) |
| Net loss and comprehensive loss | $(242,026) | $(63,564) |
| Net loss per share attributable to common stockholders, basic and diluted | $(32.37) | $(21.67) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 7,478 | 2,933 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.